Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups-Reference-Cited by-同舟云学术

Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups

Published:2021-12 Issue: Volume:125 Page:102744
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Ferri Clodoveo,Ursini Francesco^ORCID,Gragnani Laura^ORCID,Raimondo Vincenzo,Giuggioli Dilia,Foti Rosario,Caminiti Maurizio,Olivo Domenico,Cuomo Giovanna,Visentini Marcella,Cacciapaglia Fabio,Pellegrini Roberta,Pigatto Erika,Urraro Teresa^ORCID,Naclerio Caterina,Tavoni Antonio,Puccetti Lorenzo,Varcasia Giuseppe,Cavazzana Ilaria,L'Andolina Massimo,Ruscitti Piero,Vadacca Marta,Gigliotti Pietro,La Gualana Francesca,Cozzi Franco,Spinella Amelia,Visalli Elisa,Dal Bosco Ylenia,Amato Giorgio,Masini Francesco,Pagano Mariano Giuseppa,Brittelli Raffaele,Aiello Vincenzo^ORCID,Caminiti Rodolfo,Scorpiniti Daniela,Rechichi Giovanni,Ferrari Tommaso,Monti Monica,Elia Giusy^ORCID,Franceschini Franco,Meliconi Riccardo,Casato Milvia,Iannone Florenzo,Giacomelli Roberto,Fallahi Poupak^ORCID,Santini Stefano Angelo^ORCID,Zignego Anna Linda,Antonelli Alessandro^ORCID

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference31 articles.

1. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study;Pablos;Ann. Rheum. Dis.,2020

2. COVID-19 outcomes in patients with systemic autoimmune rheumatic diseases compared to the general population: a US multicenter, comparative cohort study;D'Silva;Arthritis Rheum.,2021

3. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series;Ferri;Clin. Rheumatol.,2020

4. Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases;Antonelli;Lancet Rheumatol,2021

5. COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses;Fagni;Lancet Rheumatol,2021

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjunctive and preventive measures;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. COVID-19 real world data infrastructure: A big data resource for study of the impact of COVID-19 in patient populations with immunocompromising conditions;2024-09-09

3. Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study;Rheumatology International;2024-08-13

4. A Case Report and Literature Review of a Triple-Vaccinated, Rituximab-Treated Systemic Lupus Erythematosus patient with COVID-19 pneumonia;ARP Rheumatology;2024-06-30

5. Factors associated with immune responses to SARS-CoV-2 vaccination in individuals with autoimmune diseases;JCI Insight;2024-06-04